This content is from: Patents

Switzerland changes infringement test for combination product SPCs

In a landmark decision, the Swiss Federal Supreme Court confirmed the validity of Gilead’s Truvada SPC and ruled that future SPCs for combination products must meet CJEU case law requirements

To access our in-house intelligence please request a trial here.

Read this article – and more – for a one-week period.

REQUEST ACCESS

Are you already an Managing IP subscriber? Login here

Related

Instant access to all of our content. Membership Options | One Week Trial